A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

NCT02471326 ·Status: COMPLETED ·Phase: PHASE1

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

NCT00102934 ·Status: UNKNOWN ·Phase: NA

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

NCT00050856 ·Status: COMPLETED ·Phase: PHASE3

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

NCT00021554 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

NCT00487188 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

NCT00089492 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

NCT00008866 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

NCT00488059 ·Status: TERMINATED ·Phase: PHASE4

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

NCT00705926 ·Status: COMPLETED ·Phase: PHASE1

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

NCT00025909 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

NCT00757250 ·Status: TERMINATED ·Phase: PHASE1

Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study

NCT05220358 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of Enfuvirtide in HIV-Positive Subjects

NCT00086710 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

NCT00115609 ·Status: COMPLETED ·Phase: PHASE3

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

NCT00608569 ·Status: COMPLETED ·Phase: NA

Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir

NCT06640192 ·Status: RECRUITING ·Phase: PHASE2

Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care

NCT01900080 ·Status: UNKNOWN ·Phase: NA

ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence

NCT03218592 ·Status: COMPLETED ·Phase: PHASE4

Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations

NCT00011089 ·Status: UNKNOWN ·Phase: NA

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

NCT00966160 ·Status: COMPLETED ·Phase: PHASE3

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

NCT00001899 ·Status: COMPLETED

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)

NCT01232660 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection

NCT02569502 ·Status: COMPLETED ·Phase: PHASE4

Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

NCT00109603 ·Status: COMPLETED ·Phase: NA

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

NCT00362687 ·Status: COMPLETED ·Phase: PHASE4